the meihua biont, (600873) late announcement on april 24, a wholly owned subsidiary company of lhasa holding subsidiary of meihua guang sheng medicine to apply for stock transfer system of small and medium-sized enterprises in the country(hereinafter referred to as "new three board") cartellino. in addition, wide guang sheng medicine proposed increase endowment spread, the meihua in lhasa offered $46.2 million to subscribe raw medicine 1.3356 million shares. before the capital increase, the meihua in lhasa holds a 51.761% stake in wide guang sheng medicine. after the completion of the capital increase, the meihua in lhasa will hold a 50.1342% stake in wide guang sheng medicine, is still widely raw medicine's controlling shareholder.
service hotline:400-960-0873
group the switchboard:+86 316-2359999
email:
client inquiry|webs of subsidiary members||legal statement|privacy protection
focusing on biotechnology, building and sharing better futureayx爱游戏官网注册 copyright @ 2005 meihua holdings group co., ltd . "));
mobile
registered address: kim lhasa tibet autonomous region west road no. 189
office address: no.66 huaxiang road,economic and technical development area,langfang city, hebei province 065001, china
the service hotline: 400-960-0873
tel: +86 316-2359999 fax: +86 316-2359679
email:meihua@meihuagrp.com
url:www.meihuagrp.com